Navigation Links
XELR8 Holdings Announces Continuation of 'XELR8 To A Million' Promotion
Date:7/2/2008

- Distributors Sales Success Prompts Extension of Promotion -

DENVER, July 2 /PRNewswire-FirstCall/ -- XELR8 Holdings, Inc. (Amex: BZI), a provider of functional foods, beverages and nutritional supplements, announced that "XELR8 To A Million" promotion attained a significant proportion of the $1 million sales goal for the month of June prompting management to offer distributors an opportunity to earn significant bonuses in July.

John Pougnet, CEO, noted, "Our distributors worked exceptionally hard during June and came close to attaining our ambitious goal of $1 million in sales in that month. We felt that such dedication and hard work should be rewarded even if the very aggressive sales goal was not reached. Consequently, we will be offering significant bonuses for sales leadership in July whereby distributors can earn large bonuses depending on their individual sales performance and ranking within the sales organization."

Toward the end of July, XELR8 will post the promotion's progress on its website: http://www.xelr8.com on the page/link marked "XELR8 Performs."

About XELR8 Holdings, Inc.

XELR8 Holdings, Inc. is a provider of nutritional foods and beverages designed to help enhance physical health and overall performance. XELR8 has developed a comprehensive line of nutritional supplements and functional foods designed in systems that are easy to take, simple to understand, and conveniently fit within a lifestyle. These include the Company's Eat/Drink/Snack System; Peak Performance System; and its newest market entry, Bazi(TM), a powerful, concentrated, antioxidant (Vitamins A, C & E) nutritional drink packed with eight different super fruits and berries, including the Chinese jujube plus 12 vitamins and 68 minerals, providing all the daily vitamins and minerals you need in a single, convenient, one-ounce shot.

XELR8's commitment to quality, science and research has earned the Company a loyal following of over 350 world-class athletes and an elite list of endorsers, such as 3-time World Series Champion Curt Schilling, five-time Cy Young Award Winner Randy Johnson; Super Bowl Champions Mike Alstott, Lawyer Milloy and Head Coach Mike Shanahan; professional football superstar Cadillac Williams; Olympians Briana Scurry and Caroline Lalive; Stanley Cup Winner Blake Sloan; and PGA Tour Professional Tom Pernice, Jr. XELR8 products are only available through independent distributors located throughout the nation. For more information about XELR8, please visit http://www.xelr8.com or http://www.drinkbazi.com

Contacts:

Stephen D. Axelrod, CFA

John Pougnet, CEO Alisa Steinberg (Media)

XELR8 Holdings, Inc. Wolfe Axelrod Weinberger Assoc. LLC

(303) 316-8577 (212) 370-4500

CEO@xelr8.com steve@wolfeaxelrod.com

alisa@wolfeaxelrod.com


'/>"/>
SOURCE XELR8 Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. XELR8 Holdings Announces Record First Quarter Revenue
2. XELR8 Holdings Announces Fiscal 2007 Financial Results
3. XELR8 Holdings to Announce 2007 Third Quarter Results on Wednesday, October 31, 2007
4. Settlement Hearing for In Re PainCare Holdings, Inc. ("PRZ") Securities Litigation
5. American Healthcare Holdings Ranked in Top 100 HCIT Companies
6. Critical Homecare Solutions Holdings, Inc. Reports Full Year 2007 and First Quarter 2008 Results
7. Zimmer Holdings to Partner with AmeriCares for Global Product Donation Program
8. NightHawk Radiology Holdings, Inc. Announces Final Results of Tender Offer; NightHawk Purchases 2,240,883 Shares of Its Common Stock at $8.05 per Share
9. NightHawk Radiology Holdings, Inc. Announces Preliminary Results of Its Tender Offer; NightHawk Expects to Purchase 2,367,438 Shares of Its Common Stock at $8.05 per Share
10. HMS Holdings Corp. to Present at Jefferies 2nd Annual Healthcare Conference
11. HMS Holdings Corp. to Present at Stephens 2008 Spring Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... , ... April 25, 2017 , ... Back Pain ... and back pain with a reputable physician in their area, announces the launch of ... patient information for patients who are looking for reputable physicians to help them with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the ... or chronic problems, I focus on preventative care with all my patients to alleviate possible ... questions, always feel free to contact my office and my trained staff will assist you ...
(Date:4/25/2017)... ... ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will be featured ... publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is an Emergency ... He also serves as Medical Director for the Bureau of Emergency Medical Services and ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... for large animal healthcare products, is introducing Flexadin UCII, part of the EQUISTRO ... cartilage development and joint health in horses at the immunologic level. , The ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
Breaking Medicine Technology: